King’s College London Unveils "Hybrid" Organoid System to Standardize and Scale Neural Drug Testing

King’s College London researchers developed a scalable system that turns 3D brain organoids into consistent 2D networks for high-throughput drug and gene testing.

By: AXL Media

Published: Mar 28, 2026, 11:03 AM EDT

Source: Information for this report was sourced from King’s College London

Bridging the Gap Between Complexity and Consistency

Neural organoids—miniature, lab-grown models of the human brain—have long promised to revolutionize how we study neurodevelopment and test new pharmaceuticals. However, the field has been plagued by a persistent trade-off: 3D organoids offer rich biological diversity but are notoriously inconsistent and difficult to record from, while 2D cultures are easy to monitor but lack the cellular variety of a real brain. A new study from King’s College London, published in Cell Reports Methods, appears to have found the "best of both worlds." By breaking down 3D organoids and replating them into standardized 2D networks, the research team has created a system that is both biologically complex and technically reproducible.

The Dissociation and Pooling Breakthrough

The innovation, led by Dr. Adam Pavlinek and Professors Deepak Srivastava and Anthony Vernon, centers on a process of dissociation. The team first grows traditional 3D organoids to develop a diverse array of neuron types and support cells. These organoids are then broken down into individual cells and pooled together. This pooling step is critical; it averages out the inherent "unwanted variability" between individual organoids, resulting in a consistent cell mixture. When these cells are replated onto a 2D surface, they form multiple parallel neural networks that are nearly identical in composition, providing a stable baseline for comparative genetic and pharmacological research.

High-Throughput Monitoring via Microelectrode Arrays

To capture the electrical life of these networks, the researchers grew the dissociated cells on microelectrode arrays (MEAs). Unlike 3D structures, where electrodes can typically only reach the surface, the 2D format allows for the simultaneous recording of thousands of neurons across the entire network. This configuration enabled the team to watch the neurons mature over 37 days, transitioning from the asynchronous "noise" of early development to the sophisticated, synchronized firing patterns characteristic of a mature brain. Professor Srivastava noted that this approach allows for the direct comparison of drug effects or gene variants across many parallel cultures in a way that was previously impossible.